Dalvocans 50 mg prašak za koncentrat za otopinu za infuziju
| Name | Dalvocans 50 mg prašak za koncentrat za otopinu za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-241627075 |
| Active Substance | kaspofunginacetat |
| Composition | svaka bočica sadži 50 mg kaspofungina (u obliku acetata) 1 ml koncentrata sadrži 5,2 mg kaspofungina |
| Pharmaceutical Form | prašak za koncentrat za otopinu za infuziju |
| Manufacturer | Pharmathen S.A., Pallini Attiki, Grčka Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka |
| Marketing Authorisation Holder | Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date | 09.03.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/38 |
| Registration Number | 381-12-01/70-22-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J02AX04 |
| Marketing status | Marketed |
| Shortage status | Actual |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o potrebi izbjegavanja primjene poliakrilonitrilskih membrana tijekom kontinuirane bubrežne nadomjesne terapije u bolesnika na terapiji lijekovima koji sadrže kaspofungin | 09.10.2025 | PharmaS d.o.o., Pliva Hrvatska d.o.o., Zentiva, k.s, Ligula Pharma d.o.o., Rhei Life d.o.o./Marti Farm d.o.o. |
